Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study-Reference-Cited by-同舟云学术

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study

Published:2013-02 Issue:2 Volume:24 Page:501-507
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Janus N.,Launay-Vacher V.,Thyss A.,Boulanger H.,Moranne O.,Islam M.S.,Durande J.-P.,Ducret M.,Juillard L.,Soltani Z.,Motte G.,Rottembourg J.,Deray G.,Thariat J.

Funder

Amgen

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/2/501/600484/mds344.pdf

Reference36 articles.

1. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study;Maisonneuve;Lancet,1999

2. Cancer incidence before and after kidney transplantation;Vajdic;JAMA,2006

3. Malignant tumors in hemodialysis patients;Cucković;Nephron,1996

4. Increased incidence of malignancy during chronic renal failure;Matas;Lancet,1975

5. Increased incidence of malignancy in chronic renal failure;Sutherland;Nephron,1977

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case Report of Successful Treatment with Dose-controlled mFOFOX6+Bevacizumab for Metastatic Colorectal Cancer in Patient Receiving Hemodialysis;YAKUGAKU ZASSHI;2024-08-01

2. Onkologische Herausforderungen bei Patienten mit chronischem Nierenversagen an der Dialyse und nach Transplantation;Die Nephrologie;2024-07-01

3. Chemotherapy in patients with testicular germ-cell tumors and end-stage renal disease requiring hemodialysis: two case reports;Oncology in Clinical Practice;2023-12-11

4. Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report;International Cancer Conference Journal;2023-11-13

5. Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-08-12